The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Endocan Corp are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days Endocan Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Endocan Corp is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Endocan
Endocan Corp Relative Risk vs. Return Landscape
If you would invest 0.01 in Endocan Corp on December 5, 2025 and sell it today you would earn a total of 0.00 from holding Endocan Corp or generate 0.0% return on investment over 90 days. Endocan Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Endocan, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
Endocan Corp Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Endocan Corp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Endocan Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Endocan Corp generated a negative expected return over the last 90 days
Endocan Corp has some characteristics of a very speculative penny stock
Net Loss for the year was (3.31 M) with profit before overhead, payroll, taxes, and interest of 0.
Endocan Corp currently holds about 59 in cash with (105.94 K) of positive cash flow from operations.
Endocan Corp Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Endocan Pink Sheet often depends not only on the future outlook of the current and potential Endocan Corp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Endocan Corp's indicators that are reflective of the short sentiment are summarized in the table below.
Short Long Term Debt
271.7 K
Shares Float
32.9 M
Endocan Corp Fundamentals Growth
Endocan Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Endocan Corp, and Endocan Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Endocan Pink Sheet performance.
By examining Endocan Corp's fundamental ratios, stakeholders can obtain critical insights into Endocan Corp's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Endocan Corp is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Thermic Sciences International develops and sells hemp based products. Thermic Sciences International was incorporated in 1969 and is based in Colorado Springs, Colorado. ENDOCAN CORP operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange.
Things to note about Endocan Corp performance evaluation
Checking the ongoing alerts about Endocan Corp for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Endocan Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Endocan Corp generated a negative expected return over the last 90 days
Endocan Corp has some characteristics of a very speculative penny stock
Net Loss for the year was (3.31 M) with profit before overhead, payroll, taxes, and interest of 0.
Endocan Corp currently holds about 59 in cash with (105.94 K) of positive cash flow from operations.
Evaluating Endocan Corp's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Endocan Corp's pink sheet performance include:
Analyzing Endocan Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Endocan Corp's stock is overvalued or undervalued compared to its peers.
Examining Endocan Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Endocan Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Endocan Corp's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Endocan Corp's pink sheet. These opinions can provide insight into Endocan Corp's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Endocan Corp's pink sheet performance is not an exact science, and many factors can impact Endocan Corp's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Other Information on Investing in Endocan Pink Sheet
Endocan Corp financial ratios help investors to determine whether Endocan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endocan with respect to the benefits of owning Endocan Corp security.